Peer Review History
| Original SubmissionJanuary 2, 2024 |
|---|
|
PONE-D-23-43696Mid-Twentieth Century Black-White disparities in U.S. women’s reproductive health and later- life mortality: Implications for contemporary health research and policyPLOS ONE Dear Dr. Elman, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers were enthusiastic about the significance of the work but have identified some areas where there could be more clarity, especially when considering the likely multidisciplinary audience. Please submit your revised manuscript by Jul 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Emily W. Harville Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding ethical approval in the body of your manuscript. In the Methods section, please ensure that you have specified the name of the IRB/ethics committee that approved your study. 3. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. 4. Thank you for stating the following financial disclosure: [The first two authors, C. Elman and A. O'Rand, received research project support from an NICHD Population Dynamics Research Infrastructure Program award to the Duke Population Research Center (P2C HD065563) and an NIA Centers on the Demography and Economics of Aging Program award to the Duke Center for Population Health and Aging (P30 AG034424) at the Duke Population Research Institute. The third author, A. London, received research project support from an NIA Centers of the Demography and Economics of Aging award to the Center for Aging and Policy Studies in the Aging Studies Institute at Syracuse University (P30 AG066583).]. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a well-done paper that adds to the growing evidence on women’s mortality risk associated with parity and infecundity. I genuinely enjoyed reading this manuscript - the authors skillfully situate their study within the broader context of existing evidence, demonstrating a comprehensive understanding of the relevant literature. The analyses presented are methodologically sound and rigorous, and the findings offer valuable insights into understanding the complex dynamics of underlying reproductive health disparities by race/ethnicity. I commend the authors for their outstanding work and only have very minor suggestions that focus on clarifications to further strengthen the manuscript's coherence: - In the abstract and throughout the paper, the authors claim to examine the infecundity risk and parity by race – my suggestion would be to clarify that it is “by race/ethnicity” as they analyze the sample with non-Hispanic Black and White women (i.e., the combined race and ethnicity variable is used and therefore the term race/ethnicity is more accurate to signify the combination of both race and ethnicity into a single variable). - The authors skillfully place their work in the context of previous evidence and present three aims addressed in their paper (p.11). I would like to see more specific hypotheses outlined as well (regarding the main associations and any moderation effects examined). - Under “Adjustment Measures” (p.16) the authors explain that they assigned the never-married women the mean “Age at Marriage” instead of excluding them. What is the proportion of “never married” women in the sample? It is not clear why creating a categorical variable which would allow to more accurately capturing categories of age at marriage (e.g., never married, married before 20; etc.) was not chosen instead? - In Table 1, please consider including the p-value of the difference between the two racial/ethnic groups. - In Table 2, please include the 95% CI next to reporting odds ratios. - The Discussion section is very well-written with the main findings outlined and discussed in sufficient detail. However, I would suggest enhancing the “implications for contemporary health research and policy” component indicated in the title of this paper. More specifically, based on the main findings of this study, what are the key policy implications in addressing racial/ethnic inequities in reproductive health in the US? Reviewer #2: This is an interesting paper which uses a two-step analytic process, first to separate voluntary from involuntary childlessness and therefore to estimate a risk of infecundity (involuntary childlessness) for individual women. The next step estimates the effect of this infecundity risk and of parity on later life mortality, and compares the results for black and white women in the US. The authors conclude that black women’s later life mortality risk is associated with their infecundity. The analyses seem appropriate (although I’m not an expert in these precise models and feel they could be better explained for the audience) and imaginative. Literature review and framing. However I think there are improvements the authors could make to the framing of the paper in order to make it more accessible. In particular, the focus on childlessness and post-reproductive mortality emerges rather slowly during the introduction and literature review. This could be made much clearer from the start and the reader would benefit from greater clarity in the literature review too. I also feel that the paper would benefit from closer attention to the historical context that the study cohorts were going through. In particular, I would have liked some recognition that the cohorts of women studied (born 1920-1941) were the cohorts going through childbearing during the baby boom. We know that such women had unusual marriage and childbearing patterns compared to those before and after. How might this affect conclusions? Were there differences in the experience of the baby boom that affected black and white women differently? It might be easier to conceptualise these baby boom generations as an atypical episode rather than in between two ‘cross-overs’ (lines 123-126). It would also be good to recognise (eg line 71) that historically the most important driver of childnessness was celibacy (non-marriage). Fecund women were likely to have been selected into marriage through pre-marital pregnancy. Sometimes an awful lot of work is done by the term ‘infecundity’ (eg Line 130: the use of ‘infecundity’ here seems to represent a composite of everything excluding voluntary control, but this includes a wide range of factors). How can you tell the differences between infecundity (as in the biological incapacity to conceive), exposure (eg through marriage/partnership), and voluntary childlessness (use of contraception)? Demographers have specific meaning for fecundity and fertility, but these terms are not used in the same way by every field or by the general public. Clarity in how the authors are using them would be helpful. This is also relevant for lines 169-171: Because most measures of fertility include only live births, the ‘healthy pregnant woman effect’ – surely this selection is not just about healthy pregnant women, but healthy women who produce live births. Similarly on line 191, ‘the physiological resilience to the fecund’ should be ‘the physiological resilience to be fertile’. I’m surprised that the proximate determinants of fertility framework is not mentioned in the text (Bongaarts is referenced in the literature) - this might help with the conceptualisation. In ‘Biophysiological factors’ I’m surprised that the protective effect of breastfeeding on the risk of breast cancer was not mentioned. Line 111: ‘natural fertility’ should be defined for those who are not familiar with the term In the ‘Socio-economic factors’ section (lines 175-228), some of the factors mentioned explain the increased risks associated with low parities, and some explain the increased risk of high parities: it would be helpful to the reader if these were distinguished. Line 260: ‘The RAND documents question changes and …’ I had to read this several times before I saw documents as the verb ad question as a noun rather than the other way around. I suggest a rephrase. Data. Regarding the observed parity and timing indicators (lines 301-311), age at first birth is calculated using the age of participant and the age of their first child. This implies that respondents were asked for the ages of all their children, including the age that any who had died would be had they lived. This might be subject to more error than the ages of living children, and it would be good to have an assessment of the effect of this on results. Treatment of missing data: did you do sensitivity analyses to examine how much the use of mother’s education when father’s was missing? Analytic strategy. I would have appreciated more explanation of how the combination of the logistic and count processes can distinguish voluntary and involuntary childlessness. Does this depend on an assumption that you can predict the proportion of women who are voluntarily childless from the subsequent parity distribution. Why would this be so? How do these models differ from ‘cure’ models? Lines 401-403: explain the significance of this correlation. Results. Fertility models: Age and cohort. Age (eg on line 448) presumably means age at survey, but which round of the survey? It might be less confusing to present this as cohort. If it is not cohort, what is its relevance? On line 470-1 you say that ‘age and marital age represent biological parameters of reproductive physiological maturation’ – I’m not sure how age at survey would do that, or does this now refer to age at birth? Results are conditional on surviving to the survey date: how might differential survival up to that point affect results? Descriptive information (Table 1) indicates that the parents of blacks were better educated than the parents of whites, but the black respondents themselves were worse educated. This seems unexpected – is there some sort of strange selection operating? Count model: presumably this refers just to women who are not infecund/infertile? This should be made clearer. More guidance is needed on how to interpret the models, for example the beta coefficient in Table 2. Why not also give the exponentiated values in the count bit of the Table (particularly as these are reported in the text). In the ‘always-zero’ bit of the Table, could the odds ratio be shown? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-43696R1Parity and Post-Reproductive Mortality among U.S. Black and White Women: Evidence from the Health and Retirement StudyPLOS ONE Dear Dr. Elman, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ==============================Please respond to the reviewer's additional question.============================== Please submit your revised manuscript by Oct 03 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Emily W. Harville Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for your thorough and thoughtful responses to the questions and comments the reviewers raised during the review process. I appreciate the care and attention you have given to addressing each point. I have reviewed your revisions and responses and am satisfied with the changes made. I have no further comments or questions at this time. Reviewer #2: Thank you for your careful responses to my previous questions. I have just one follow up question regarding my question 14: My question and your response were: 14. Data. Regarding the observed parity and timing indicators (lines 301-311), age at first birth is calculated using the age of participant and the age of their first child. This implies that respondents were asked for the ages of all their children, including the age that any who had died would be had they lived. This might be subject to more error than the ages of living children, and it would be good to have an assessment of the effect of this on results. Response: Although the HRS did query respondents about their number of children, it did not ask them about the age(s) of all children born or list dates of all children born. Rather, it only asked them to report the age of their oldest and youngest living child with whom they were in contact in the baseline interview. The RAND family database harmonized this information. The codebook notes: Age of the respondent’s youngest kid and oldest kid…variables are derived from the best guess kid’s age in the Respondent-kid file. We noticed that some of the ages are over 80 years old. Page 247, RAND HRS Family Data 2018 (V2). Santa Monica, CA (July 2023). 018v2.pdf Change we made: To clarify this we have added, Lines 337-339: (The RAND family database provides information only about each participant’s oldest and youngest currently-living child with whom they were in contact at the intake interview, not all children born). Follow-up question: I appreciate you including this information, but I still think it is worth including a brief assessment of the possible effect of this on results. Clearly if their oldest or youngest child had died (or they had lost contact with them), then ages at first or last birth will be over or under-stated. Given that it is possible that the risk of child death is correlated with maternal health, how might this affect results? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dovile Vilda Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Parity and Post-Reproductive Mortality among U.S. Black and White Women: Evidence from the Health and Retirement Study PONE-D-23-43696R2 Dear Dr. Elman, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Emily W. Harville Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-43696R2 PLOS ONE Dear Dr. Elman, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Emily W. Harville Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .